Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hamid Afshar-Kharaghan

Clinical Cardiac Electrophysiology Houston, TX Medical Doctor

NPI 1740474246 CMS profile 261268

1504 Taub Loop, Ste 1225, Houston, TX 77030

Open in the dashboard

General payments

$111,929

653 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$5,658 paid to institutions, not to them · program year 2025

Through program year 2025, Hamid Afshar-Kharaghan of Houston, TX is reported in the CMS Open Payments database as having received $111,929 across 653 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $5,658 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,636 57
2024 General $11,285 96
2023 General $30,259 151
2022 General $23,596 133
2021 General $15,771 82
2020 General $7,759 47
2019 General $15,623 87

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hamid Afshar-Kharaghan
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Hamid Afshar-Kharaghan were reported at $7,636. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Hamid Afshar-Kharaghan Clinical Cardiac Electrophysiology median Middle half National median
2019 $15,623 $2,361 $585–$8,260 $163
2020 $7,759 $993 $247–$4,351 $114
2021 $15,771 $1,185 $326–$4,739 $132
2022 $23,596 $2,073 $554–$6,789 $149
2023 $30,259 $2,568 $759–$8,159 $160
2024 $11,285 $2,557 $703–$7,403 $164
2025 $7,636 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $64,284 355 payments
  2. Boston Scientific Corporation $16,365 103 payments
  3. Impulse Dynamics (USA) Inc. $12,978 28 payments
  4. Biotronik Inc. $6,473 31 payments
  5. Medtronic, Inc. $5,332 71 payments
  6. Philips Electronics North America Corporation $1,539 9 payments
  7. Respicardia, Inc. $1,171 4 payments
  8. CVRx, Inc. $1,146 6 payments
  9. CardioFocus, Inc. $960 8 payments
  10. Biosense Webster, Inc. $769 9 payments
  11. Other $910 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $39,879 538 payments
  2. Consulting Fee $25,053 24 payments
  3. Travel and Lodging $23,647 78 payments
  4. Honoraria $9,500 4 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,000 5 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $2,850 3 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,000 1 payment
Products named General payments · program years 2019–2025
  1. OPTIMIZER Cardiovascular Device $10,006 22 payments
  2. OPTIMIZER Cardiovascular Device $10,006 22 payments
  3. AVEIR Cardiac Rhythm Management $6,361 44 payments
  4. Allure CRT Pacemaker $5,379 5 payments
  5. AVEIR Cardiac Rhythm Management $5,214 25 payments
  6. Acculink carotid stent system $5,018 2 payments
  7. Confirm Rx $4,775 12 payments
  8. ACCENT $4,355 15 payments
  9. GALLANT $4,010 10 payments
  10. AVEIR Cardiac Rhythm Management $3,972 21 payments
  11. Other $48,592 413 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

653 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record